| Company Name: | Physicians Realty Trust | | Ticker Symbol: | DOC | | CIK Number: | 0001574540 | | WWW Address: | http://www.docreit.com |
| CEO: | John T. Thomas | | No. of Employees: | 41 |
| Common Issue Type: | CS | | Business Description: | Physicians Realty Trust is a healthcare real estate company that owns, acquires, selectively develops, and manages healthcare properties leased to physicians, hospitals and healthcare delivery systems.
|
| | | Industry Information: | TELECOMMUNICATIONS - Communication Equipment [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 21.6 |  0.08 | - | - | 21.55 | 21.72 | 21.41 | 2580079 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 3,315.5 | 153.5 | 0.00 | 0.22 | 0.92 | 97.8 | 4.2 | 22.03 - 17.12 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 21.60 | $ | | PE Ratio - LTM | 97.8 | |
| Market Capitalisation | 3,315.5 | mil |
| Latest Shares Outstanding | 153.5 | mil |
| Earnings pS (EPS) | 0.22 | $ |
| Dividend pS (DPS) | 0.92 | ¢ |
| Dividend Yield | 4.2 | % |
| Dividend Payout Ratio | 4 | % |
| Revenue per Employee | | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 90.3 | mil |
| Float as % of Shares Outstanding | 0.7 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 72.6 | % |
| EBITDA Margin | 60.5 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 10.6 | % |
| Return on Assets (ROA) | 1.2 | % |
| Return on Equity (ROE) | 2.0 | % |
| Return on Capital Invested (ROCI) | 2.5 | % |
| Current Ratio | 0.3 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 2.3 | |
| Total Debt/Equity (Gearing Ratio) | 0.57 | |
| LT Debt/Total Capital | 36.0 | % |
| Working Capital pS | -0.35 | $ |
| Cash pS | 0.00 | $ |
| Book-Value pS | 13.17 | $ |
| Tangible Book-Value pS | 11.33 | $ |
| Cash Flow pS | 0.99 | $ |
| Free Cash Flow pS | 0.89 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.64 | |
| Price/Tangible Book Ratio | 0.00 | |
| Price/Cash Flow | 21.9 | |
| Price/Free Cash Flow | 24.2 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.92 |
| Current Dividend Yield | 4.2 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 4.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.6 | | 1,256,000 | 4,538,880 |
| 4 Weeks | 21.85 | 20.23 | 20.33 | 5.9 | 5 | 1,198,087 | 25,159,839 |
| 13 Weeks | 21.85 | 18.75 | 19.76 | 8.9 | 6 | 1,273,980 | 81,534,771 |
| 26 Weeks | 21.85 | 18.18 | 18.44 | 16.7 | 9 | 1,154,102 | 145,416,862 |
| 52 Weeks | 22.03 | 17.12 | 21.11 | 1.9 | -16 | 1,061,833 | 267,582,075 |
| YTD | 21.85 | 18.18 | - | 14.8 | 7 | 1,162,208 | 142,951,633 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 21.62 | 21.43 | 20.39 | 19.51 | 19.56 | 0.00 | 0.00 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.77 | 1.0 | 1.43 |
| Income | | 1.2 | |
| Dividend | | 0.7 | 0.84 |
| Capital Spending | 1.11 | NA | 3.99 |
| R&D | 0.00 | NA | 16.14 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 31.4 | 54.2 | 0.3 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -0.08 | -0.01 | 0.07 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -1.86 |
| Current Ratio | 0.3 |
| Quick Ratio (Acid Test) | 0.3 |
| Liquidity Ratio (Cash) | 0.39 |
| Receivables Turnover | 37.8 |
| Average Collection Period | 10 |
| Working Capital/Equity | 0.0 |
| Working Capital pS | -0.39 |
| Cash-Flow pS | 0.96 |
| Free Cash-Flow pS | 0.87 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.94 |
| Financial Leverage Ratio (Assets/Equity) | 0.6 |
| Debt Ratio | 34.3 |
| Total Debt/Equity (Gearing Ratio) | 0.57 |
| LT Debt/Equity | 0.57 |
| LT Debt/Capital Invested | 39.2 |
| LT Debt/Total Liabilities | 100.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.85 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 1.15 |
| Current P/E Ratio - LTM | 97.80 |
| Enterprise Value (EV)/EBITDA | 30.46 |
| Enterprise Value (EV)/Free Cash Flow | 31.12 |
| Dividend Yield | 4.2 |
| Price/Tangible Book Ratio - LTM | 0.00 |
| Price/Book Ratio - LTM | 1.64 |
| Price/Cash Flow Ratio | 21.9 |
| Price/Free Cash Flow Ratio - LTM | 24.2 |
| Price/Sales Ratio | 0.00 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 100.1 |
| 5-Y Low P/E Ratio | 50.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 31 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 10.74 |
| Current Liabilities pS | 0.85 |
| Tangible Book Value pS - LTM | 11.33 |
| Book Value pS - LTM | 13.17 |
| Capital Invested pS | 17.78 |
| Cash pS - LTM | 0.00 |
| Cash Flow pS - LTM | 0.99 |
| Free Cash Flow pS - LTM | 0.89 |
| Earnings pS (EPS) | 0.22 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 47.08 |
| Free Cash Flow Margin 5YEAR AVG | -129.07 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 0.14 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.09 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.0 |
| Assets Productivity | 0.10 |
| Return on Assets (ROA) | 0.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.0 |
| Gross Profit Margin | 72.6 |
| Gross Profit Margin - 5YEAR AVRG. | 0.7 |
| EBITDA Margin - LTM | 60.5 |
| EBIT Margin - LTM | 22.9 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 0.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 1,012,766 |
| Revenue per Employee | |
| Net Income per Employee | |
| Average Collection Period | 1,012,766 |
| Receivables Turnover | 37.8 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.84 |
| Assets/Revenue | 10.00 |
| Net Working Capital Turnover | -4.50 |
| Fixed Assets Turnover | 0.08 |
| Total Assets Turnover | 0.1 |
| Revenue per $ Cash | 15.56 |
| Revenue per $ Plant | 0.00 |
| Revenue per $ Common Equity | 0.14 |
| Revenue per $ Capital Invested | 0.09 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 7.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 1.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
| | |  |  | | |
